Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Role of juxtamembrane and transmembrane domains in the mechanism of natriuretic peptide receptor A activation.

Parat M, Blanchet J, De Léan A.

Biochemistry. 2010 Jun 8;49(22):4601-10. doi: 10.1021/bi901711w.

PMID:
20214400
2.

Role of extracellular domain dimerization in agonist-induced activation of natriuretic peptide receptor A.

Parat M, McNicoll N, Wilkes B, Fournier A, De Léan A.

Mol Pharmacol. 2008 Feb;73(2):431-40. Epub 2007 Oct 26.

PMID:
17965196
3.

Biochemical and pharmacological characterization of P-site inhibitors on homodimeric guanylyl cyclase domain from natriuretic peptide receptor-A.

Joubert S, McNicoll N, De Léan A.

Biochem Pharmacol. 2007 Apr 1;73(7):954-63. Epub 2006 Dec 10.

PMID:
17196175
4.
5.
6.
7.
8.

Photolabeling study of the ligand binding domain of natriuretic peptide receptor A: development of a model.

Jossart C, Coupal M, McNicoll N, Fournier A, Wilkes BC, De Léan A.

Biochemistry. 2005 Feb 22;44(7):2397-408.

PMID:
15709752
9.

Development of a selective peptide antagonist for the human natriuretic peptide receptor-B.

Deschênes J, Duperé C, McNicoll N, L'Heureux N, Auger F, Fournier A, De Léan A.

Peptides. 2005 Mar;26(3):517-24.

PMID:
15652659
10.

Natriuretic peptide receptor A activation stabilizes a membrane-distal dimer interface.

De Léan A, McNicoll N, Labrecque J.

J Biol Chem. 2003 Mar 28;278(13):11159-66. Epub 2003 Jan 22.

11.

Short-term inverse-agonist treatment induces reciprocal changes in delta-opioid agonist and inverse-agonist binding capacity.

Piñeyro G, Azzi M, De Léan A, Schiller P, Bouvier M.

Mol Pharmacol. 2001 Oct;60(4):816-27.

PMID:
11562445
12.

Reduced activity of the NPR-A kinase triggers dephosphorylation and homologous desensitization of the receptor.

Joubert S, Labrecque J, De Léan A.

Biochemistry. 2001 Sep 18;40(37):11096-105.

PMID:
11551207
13.
14.

Development of a photolabile ligand for the endothelin-A receptor of endothelin.

Tessier S, Langlois C, Brkovic A, Coupal M, De Léan A, Fournier A.

J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S53-4.

PMID:
11078334
15.

Comparative binding study of rat natriuretic peptide receptor-A.

Marquis M, Fenrick R, Pedro L, Bouvier M, De Léan A.

Mol Cell Biochem. 1999 Apr;194(1-2):23-30.

PMID:
10391120
16.

Development of p-benzoylbenzoylated [N,C,rANP(1-28)]pBNP32 (pBNP1) derivatives and affinity photolabeling of the bovine NPR-A receptor.

Coupal M, De Léan A, McNicoll N, Fournier A.

Biochem Biophys Res Commun. 1999 Apr 29;258(1):81-6.

PMID:
10222239
17.
18.

Characterization of the phosphorylation state of natriuretic peptide receptor-C.

Pedro L, Fenrick R, Marquis M, McNicoll N, De Léan A.

Mol Cell Biochem. 1998 Jan;178(1-2):95-101.

PMID:
9546587
19.

Glycosylation of asparagine 24 of the natriuretic peptide receptor-B is crucial for the formation of a competent ligand binding domain.

Fenrick R, Bouchard N, McNicoll N, De Léan A.

Mol Cell Biochem. 1997 Aug;173(1-2):25-32.

PMID:
9278251
20.
21.

Hydrophobic forces are responsible for the folding of a highly potent natriuretic peptide analogue at a membrane mimetic surface: an NMR study.

Carpenter KA, Wilkes BC, De Léan A, Fournier A, Schiller PW.

Biopolymers. 1997;42(1):37-48.

PMID:
9209157
22.

Glycosylation is critical for natriuretic peptide receptor-B function.

Fenrick R, McNicoll N, De Léan A.

Mol Cell Biochem. 1996 Dec 20;165(2):103-9.

PMID:
8979258
23.
24.

Localization by photoaffinity labeling of natriuretic peptide receptor-A binding domain.

McNicoll N, Gagnon J, Rondeau JJ, Ong H, De Léan A.

Biochemistry. 1996 Oct 1;35(39):12950-6.

PMID:
8841141
25.

Direct chronotropic effects of atrial and C-type natriuretic peptides in anaesthetized dogs.

Beaulieu P, Cardinal R, De Léan A, Lambert C.

Br J Pharmacol. 1996 Aug;118(7):1790-6.

26.

The H295R human adrenocortical cell line contains functional atrial natriuretic peptide receptors that inhibit aldosterone biosynthesis.

Bodart V, Rainey WE, Fournier A, Ong H, De Léan A.

Mol Cell Endocrinol. 1996 Apr 19;118(1-2):137-44.

PMID:
8735599
27.

A role for protein tyrosine kinase in the steroidogenic pathway of angiotensin II in bovine zona glomerulosa cells.

Bodart V, Ong H, De Léan A.

J Steroid Biochem Mol Biol. 1995 Jul;54(1-2):55-62.

PMID:
7632615
29.

Stoichiometry of the atrial natriuretic factor-R1 receptor complex in the bovine zona glomerulosa.

Rondeau JJ, McNicoll N, Gagnon J, Bouchard N, Ong H, De Léan A.

Biochemistry. 1995 Feb 21;34(7):2130-6.

PMID:
7857923
30.

Evaluation of conformational and binding characteristics of various natriuretic peptides and related analogs.

Mimeault M, De Léan A, Lafleur M, Bonenfant D, Fournier A.

Biochemistry. 1995 Jan 24;34(3):955-64.

PMID:
7827054
31.
32.

Cloning and functional expression of the bovine natriuretic peptide receptor-B (natriuretic factor R1c subtype.

Fenrick R, Babinski K, McNicoll N, Therrien M, Drouin J, De Léan A.

Mol Cell Biochem. 1994 Aug 31;137(2):173-82.

PMID:
7845391
33.

Distribution and regulation of natriuretic factor-R1C receptor subtypes in mammalian cell lines.

Féthière J, Graihle R, Larose L, Babinski K, Ong H, De Léan A.

Mol Cell Biochem. 1993 Jul 7;124(1):11-6.

PMID:
8232274
34.

The structure and dynamics of the granulocyte macrophage colony-stimulating factor receptor defined by the ternary complex model.

Hoang T, De Léan A, Haman A, Beauchemin V, Kitamura T, Clark SC.

J Biol Chem. 1993 Jun 5;268(16):11881-7.

35.

Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype.

Mimeault M, Fournier A, Féthiere J, De Léan A.

Mol Pharmacol. 1993 May;43(5):775-82.

PMID:
8502232
36.

Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene.

Drouin J, Sun YL, Chamberland M, Gauthier Y, De Léan A, Nemer M, Schmidt TJ.

EMBO J. 1993 Jan;12(1):145-56.

37.

C-type natriuretic peptide in bovine chromaffin cells. The regulation of its biosynthesis and secretion.

Babinski K, Féthière J, Roy M, De Léan A, Ong H.

FEBS Lett. 1992 Nov 30;313(3):300-2.

38.

Phosphorylation of atrial natriuretic factor R1 receptor by serine/threonine protein kinases: evidences for receptor regulation.

Larose L, Rondeau JJ, Ong H, De Léan A.

Mol Cell Biochem. 1992 Oct 7;115(2):203-11.

PMID:
1280321
39.

Mechanism of halothane attenuation of isometric tension induced by serotonin in isolated canine coronary artery rings.

Blaise G, Dumont L, Buluran J, Omri A, Sill C, De Lean A.

J Cardiovasc Pharmacol. 1992 Sep;20(3):445-50.

PMID:
1279291
40.

Homodimer formation is rate-limiting for high affinity DNA binding by glucocorticoid receptor.

Drouin J, Sun YL, Tremblay S, Lavender P, Schmidt TJ, de Léan A, Nemer M.

Mol Endocrinol. 1992 Aug;6(8):1299-309.

PMID:
1406707
41.
42.

Highly efficient photoaffinity labeling of the hormone binding domain of atrial natriuretic factor receptor.

McNicoll N, Escher E, Wilkes BC, Schiller PW, Ong H, De Léan A.

Biochemistry. 1992 May 12;31(18):4487-93.

PMID:
1316147
43.

Production of polyclonal antibody to the bovine adrenal atrial natriuretic factor-R1 receptor.

Rondeau JJ, McNicoll N, Lord C, Larose L, Meloche S, Gagnon J, Ong H, De Léan A.

J Recept Res. 1992;12(4):485-505.

PMID:
1281231
44.

Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype.

Féthière J, De Léan A.

Mol Pharmacol. 1991 Dec;40(6):915-22.

PMID:
1684636
45.

Allosteric modulation by ATP of the bovine adrenal natriuretic factor R1 receptor functions.

Larose L, McNicoll N, Ong H, De Léan A.

Biochemistry. 1991 Sep 17;30(37):8990-5.

PMID:
1654083
46.

Sites of action of angiotensin II, atrial natriuretic factor and guanabenz, on aldosterone biosynthesis.

Brochu M, Ong H, De Léan A.

J Steroid Biochem Mol Biol. 1991 May;38(5):575-82.

PMID:
1828176
47.

Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit.

Marleau S, Nguyen TT, Du Souich P, Bellemare M, De Lean A, Ong H.

Drug Metab Dispos. 1991 Jan-Feb;19(1):194-9.

PMID:
1673398
48.

Differential regulation of natriuretic peptide biosynthesis in bovine adrenal chromaffin cells.

Nguyen TT, Babinski K, Ong H, De Lean A.

Peptides. 1990 Sep-Oct;11(5):973-8.

PMID:
2149452
49.

Hydrodynamic properties of the angiotensin II receptor from bovine adrenal zona glomerulosa.

Rondeau JJ, McNicoll N, Escher E, Meloche S, Ong H, De Léan A.

Biochem J. 1990 Jun 1;268(2):443-8.

50.

IL-3 inhibits the binding of GM-CSF to AML blasts, but the two cytokines act synergistically in supporting blast proliferation.

Onetto-Pothier N, Aumont N, Haman A, Park L, Clark SC, De Léan A, Hoang T.

Leukemia. 1990 May;4(5):329-36.

PMID:
2201826

Supplemental Content

Loading ...
Support Center